Takeda Pharmaceutical Co Ltd - Common Stock - Foreign

Historical Holders from Q1 2014 to Q3 2025

Type / Class
Equity / Common Stock - Foreign
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
870,576
Holdings value
$25,403,812
% of all portfolios
0%
Number of holders
2
Number of buys
2
Average buys %
+0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Takeda Pharmaceutical Co Ltd - Common Stock - Foreign

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 870,576 $25,403,812 +$742,207 $29.2 2
2025 Q2 845,147 $25,965,400 -$1,511,976 $30.68 2
2025 Q1 894,352 $26,317,716 +$727,605 $29.47 2
2024 Q4 869,622 $23,109,212 +$22,209,703 $26.59 2
2024 Q3 33,812 $969,844 +$6,052 $28.62 2
2024 Q2 33,600 $871,436 -$155,614 $25.94 1
2024 Q1 39,600 $1,094,760 -$580,555 $27.65 1
2023 Q4 60,600 $1,742,605 -$59,726 $28.76 1
2023 Q3 62,677 $1,949,298 +$966,516 $31.1 1
2023 Q2 31,600 $989,748 -$36,239 $31.32 1
2023 Q1 32,757 $1,070,651 +$980,539 $32.68 1
2022 Q4 2,757 $85,900 $31.16 1
2022 Q3 2,757 $71,751 $26.02 1
2022 Q2 2,757 $77,481 -$758,791 $28.1 1
2022 Q1 29,757 $857,590 $28.82 1
2021 Q4 29,757 $810,627 +$75,105 $27.24 1
2021 Q3 27,000 $895,120 -$33,153 $33.15 1
2021 Q2 28,000 $938,211 $33.51 1
2021 Q1 28,000 $1,009,774 +$1,009,774 $36.06 1
2015 Q4 0 $0 -$988,000 0
2015 Q3 22,600 $988,000 +$12,000 $43.72 2
2015 Q2 10,600 $512,000 -$1,077,132 $48.3 1
2015 Q1 32,900 $1,646,000 $50.03 1
2014 Q4 32,900 $1,371,000 -$287,535 $41.67 1
2014 Q3 39,800 $1,730,000 -$39,121 $43.47 1
2014 Q2 40,700 $1,888,000 -$208,747 $46.39 1
2014 Q1 45,200 $2,147,000 -$28,500 $47.5 1